medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2018, Number 2

<< Back

Rev Invest Clin 2018; 70 (2)

Association of Intron-2 Variable Numbers of an 86-bp Tandem Repeat- Polymorphisms of Interleukin-1 Receptor Antagonist Gene and Idiopathic Recurrent Spontaneous Abortion

Avila-Vergara MA, Peraza-Garay FJ, Meraz-Cruz N, Hernandez-Guerrero C, Palacios-Gonzalez B, Vadillo-Ortega F

Language: English
References: 44
Page: 96-102
PDF size: 105.33 Kb.


ABSTRACT

Background: It has been proposed that abnormal modulation of inflammatory response is involved in the physiopathology of idiopathic recurrent spontaneous abortion (iRSA). Factors that may participate in this process include the genetic background such as carrying specific polymorphisms of genes with functional effects. Objective: The objective is to study the association between iRSA and the frequency of intron-2 variable number tandem repeat-polymorphisms of interleukin-1 receptor antagonist gene (IL1RN). Methods: We conducted a case–control study including 108 women with iRSA and 103 controls. Five allelic variants of IL1RN were determined by polymerase chain reaction (PCR) product length analysis. Results: The most frequent IL1RN allele in this population was IL1RN*1, which was present in 78% of cases and 94% of controls, and allele IL1RN*2, in 45 (20.8%) cases and 12 (5.8%) controls. Allele IL1RN*2 was significantly associated with iRSA (odds ratio = 4.28, 95% confidence interval 2.2-8.4; p = 0.000). Conclusion: Carrying allele IL1RN*2 had a strong association with iRSA in Mexican women. This polymorphism codifies for a low-function protein, which may allow for increased activity of IL-1 pro-inflammatory axis in iRSA.


REFERENCES

  1. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci. 2011;1221:80-7.

  2. Jabbour HN, Sales KJ, Catalano RD, Norman JE. Inflammatory pathways in female reproductive health and disease. Reproduction. 2009;138:903-19.

  3. Weiss G, Goldsmith LT, Taylor RN, Bellet D, Taylor HS. Inflammation in reproductive disorders. Reprod Sci. 2009;16:216-29.

  4. Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care, 2017. Fertil Steril. 2017;108:393-406.

  5. Kolte AM, Bernardi LA, Christiansen OB, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015;30:495-8.

  6. Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL- 1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol. 2011; 29:447-91.

  7. Imakawa K, Chang KT, Christenson RK. Pre-implantation conceptus and maternal uterine communications: molecular events leading to successful implantation. J Reprod Dev. 2004;50:155-69.

  8. De los Santos MJ, Mercader A, Francés A, et al. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biol Reprod. 1996;54:563-74.

  9. Sarno J, Schatz F, Huang SJ, Lockwood C, Taylor HS. Thrombin and interleukin-1beta decrease HOX gene expression in human first trimester decidual cells: implications for pregnancy loss. Mol Hum Reprod. 2009;15:451-7.

  10. Giannubilo SR, Landi B, Pozzi V, et al. The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. Cytokine. 2012;58:50-6.

  11. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today. 1991; 12:404-10.

  12. Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol. 1995;15:77-105.

  13. Arend WP, Gabay C. Physiologic role of interleukin-1 receptor antagonist. Arthritis Res. 2000;2:245-8.

  14. Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin 1-receptor antagonist. N Engl J Med. 2009;360:2426-37.

  15. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 2002;34:204-9.

  16. Patterson D, Jones C, Hart I, et al. The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics. 1993;15:173-6.

  17. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993;91:403-4.

  18. Perni SC, Vardhana S, Tuttle SL, et al. Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin- 1beta levels, and history of spontaneous abortion. Am J Obstet Gynecol. 2004;191:1318-23.

  19. Unfried G, Tempfer C, Schneeberger C, et al. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril. 2001;75:683-7.

  20. Witkin SS, Vardhana S, Yih M, et al. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin- 1beta and interleukin-1 receptor antagonist and pregnancy outcome. Am J Obstet Gynecol. 2003;189:1413-7.

  21. Dai MZ, Pan YQ, Xu DP, et al. IL-1 receptor antagonist gene polymorphism in idiopathic recurrent spontaneous abortion in a chinese han population. Int J Immunogenet. 2010;37:393-6.

  22. Levrant S, Coulam CB, Jeyendran RS. Interleukin 1 receptor antagonist gene polymorphisms are not risk factors for recurrent pregnancy loss: evaluation of couples. Am J Reprod Immunol. 2008;60:224-8.

  23. Genç MR, Gerber S, Nesin M, Witkin SS. Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery. Am J Obstet Gynecol. 2002;187:157-63.

  24. Prutsch N, Fock V, Haslinger P, et al. The role of interleukin-1β in human trophoblast motility. Placenta. 2012;33:696-703.

  25. Flamigni C, Bulletti C, Polli V, et al. Factors regulating interaction between trophoblast and human endometrium. Ann N Y Acad Sci. 1991;622:176-90.

  26. Kariya M, Kanzaki H, Takakura K, et al. Interleukin-1 inhibits in vitro decidualization of human endometrial stromal cells. J Clin Endocrinol Metab. 1991;73:1170-4.

  27. Frank GR, Brar AK, Jikihara H, Cedars MI, Handwerger S. Interleukin- 1 beta and the endometrium: an inhibitor of stromal cell differentiation and possible autoregulator of decidualization in humans. Biol Reprod. 1995;52:184-91.

  28. Kniss DA, Zimmerman PD, Garver CL, Fertel RH. Interleukin-1 receptor antagonist blocks interleukin-1-induced expression of cyclooxygenase-2 in endometrium. Am J Obstet Gynecol. 1997;177:559-67.

  29. Simón C, Valbuena D, Krüssel J, et al. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium. Fertil Steril. 1998;70:896-906.

  30. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995;99:303-10.

  31. Dewberry R, Holden H, Crossman D, Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20: 2394-400.

  32. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998;28:2598-602.

  33. Buchs N, di Giovine FS, Silvestri T, et al. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2001;2: 222-8.

  34. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998;47:195-8.

  35. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002;13:323-40.

  36. Wang J, Wu F, Xie Q, et al. Anakinra and etanercept prevent embryo loss in pregnant nonobese diabetic mice. Reproduction. 2015;149:377-84.

  37. Nguyen DP, Genc M, Vardhana S, et al. Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet Gynecol. 2004;104:293-300.

  38. Xu DP, Ruan YY, Pan YQ, et al. VNTR polymorphism of human IL1RN in Chinese Han and she ethnic populations. Int J Immunogenet. 2011;38:13-6.

  39. Karhukorpi J, Laitinen T, Kivelä H, Tiilikainen A, Hurme M. IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion. J Reprod Immunol. 2003;58:61-7.

  40. Nair RR, Khanna A, Singh K. Association of interleukin 1 receptor antagonist (IL1RN) gene polymorphism with recurrent pregnancy loss risk in the north Indian population and a metaanalysis. Mol Biol Rep. 2014;41:5719-27.

  41. Gremlich S, Fratta S, Rebellato E, et al. Interleukin-1 receptor antagonist gene (IL-1RN) polymorphism is a predictive factor of clinical pregnancy after IVF. Hum Reprod. 2008; 23:1200-6.

  42. Linjawi S, Li TC, Laird S, Blakemore A. Interleukin-1 receptor antagonist and interleukin-1 beta polymorphisms in women with recurrent miscarriage. Fertil Steril. 2005;83:1549-52.

  43. Choi YK, Kwak-Kim J. Cytokine gene polymorphisms in recurrent spontaneous abortions: a comprehensive review. Am J Reprod Immunol. 2008;60:91-110.

  44. Saravelos SH, Li TC. Unexplained recurrent miscarriage: how can we explain it? Hum Reprod. 2012;27:1882-6




2020     |     www.medigraphic.com